Enveric Biosciences (ENVB) FCF Margin Growth (3y) (2017 - 2020)
Enveric Biosciences (ENVB) FCF Margin Growth (3y) (2017 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -3,088.00 |
| 10 | Enveric Biosciences | 5.62 Mn | -2.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -393.00 |
| Jun 30, 2020 | 280.00 |
| Mar 31, 2020 | -289.00 |
| Dec 31, 2019 | 3,269.00 |
| Jun 30, 2019 | 17.00 |
| Mar 31, 2019 | -963.00 |
| Dec 31, 2018 | -1,510.00 |
| Sep 30, 2018 | 6,067.00 |
| Jun 30, 2018 | 2,292.00 |
| Mar 31, 2018 | 357.00 |
| Jun 30, 2017 | -1,284.00 |